Sign Up Today and Learn More About Citryll Stock
Invest in or calculate the value of your shares in Citryll or other pre-IPO companies through EquityZen's platform.
Citryll Stock (CITR)
Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.
About Citryll Stock
Founded
2015
Industries
Science and Engineering, Health Care, Biotechnology
Citryll Press Mentions
Stay in the know about the latest news on Citryll
Citryll Demonstrates a Broader Therapeutic Potential for CIT-013 in the Treatment of Inflammatory Disorders
globenewswire • Feb 20, 2025
Citryll Demonstrates a Broader Therapeutic Potential for CIT-013 in the Treatment of Inflammatory Disorders
morningstar • Feb 20, 2025
Antibody binding to citrullinated histone 2a and/or 4
patents • Feb 07, 2025
Dosage
patents • Feb 07, 2025
Inhibition of eosinophilic traps
patents • Feb 07, 2025
Citryll Management
Leadership team at Citryll
CEO
Helmuth van Es
CSO
Renato Chirivi
Join now and verify your accreditation status to gain access to:
- Citryll Current Valuation
- Citryll Stock Price
- Citryll Management
- Available deals in Citryll and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Citryll Cap Table and Funding History by Share Class and Liquidity Preferences
- Citryll Revenue and Financials
- Citryll Highlights
- Citryll Business Model
- Citryll Risk Factors
- Citryll Research Report from SACRA Research
Trading Citryll Stock
How to invest in Citryll stock?
Accredited investors can buy pre-IPO stock in companies like Citryll through EquityZen funds. These investments are made available by existing Citryll shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Citryll stock?
Shareholders can sell their Citryll stock through EquityZen's private company marketplace. EquityZen's network includes over 350K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 45K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
